查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1888668

骨關節炎治療市場規模、佔有率和趨勢分析報告：按產品、應用、主要用戶、地區和細分市場預測（2025-2033 年）

Osteoarthritis Therapeutics Market Size, Share & Trends Analysis Report By Product, By Application, By Primary User, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

骨關節炎治療市場摘要

2024年全球骨關節炎治療市場規模估計為50.2億美元，預計2033年將達到108.9億美元。

預計2025年至2033年，全球骨關節炎治療市場規模將以9.0%的複合年成長率成長。 2024年，全球骨關節炎治療市場規模估計為50.2億美元，預計2033年將達到108.9億美元，2025年至2033年的複合年成長率為9.0%。

根據2020年全球疾病負擔（GBD）研究，全球約有5.95億人患有骨關節炎，佔全球人口的7.6%。這一數字持續成長，主要原因是人口結構變化和生活方式因素，例如人口老化和肥胖。 2024年11月發布的GBD報告指出，骨關節炎新發病例急劇增加，光是2021年就記錄了約4.663億例。由於這種疾病主要影響負重關節，尤其是膝關節，日益引起全球醫療保健系統的關注。骨關節炎盛行率的上昇在老年人族群中尤為顯著。根據美國疾病管制與預防中心（CDC）2024年2月發布的數據，關節炎的發生率老齡化顯著增加。 75歲及以上成年人的關節炎盛行率高達53.9%，凸顯了老齡化與骨關節炎之間的密切關聯。

人口老化是市場成長的主要驅動力，世界衛生組織（世衛組織）預測，到2050年，全球16%的人口將達到或超過65歲。隨著老年人口的成長，尤其是在日本和歐洲等老化地區，對老齡化骨關節炎治療的需求也不斷增加。根據世衛組織2023年7月發布的報告，73%的骨關節炎患者年齡在55歲及以上，凸顯了老年人族群骨關節炎的盛行率上升。為了應對這一人口結構變化，醫療保健產業正致力於開發滿足老年患者獨特需求的治療方法，並考慮到許多患者存在多種合併症。截至2024年10月，醫療保健系統越來越重視老年護理，重點是開發能夠改善老年骨關節炎患者活動能力和整體生活品質的治療方法。此外，人口老化加劇，推動了對臨床研究的投資，以開發創新治療方法，如生物製藥和再生藥物，旨在減緩疾病進展並改善關節功能。

推動骨關節炎治療市場發展的另一個關鍵因素是運動傷害和意外事故導致的關節損傷發生率不斷上升。隨著參與體育運動和身體活動的人數持續增加，導致關節損傷並加速骨關節炎發展的風險也隨之增加。這些損傷不僅直接影響治療方法，也促使人們更加重視關節健康管理。根據國際勞工組織（ILO）2024年的報告，全球每年約有3.95億工人遭受非致命性工傷，其中許多會導致長期關節損傷並最終發展為骨關節炎。此外，世界衛生組織（WHO）報告稱，到2024年，每年約有440萬人死於傷害，其中大部分與道路交通事故有關。這種日益增強的意識促使人們更加關注預防措施，例如營養補充劑和物理療法，以及旨在維護關節健康和促進康復的新型骨關節炎治療方法的研發。因此，骨關節炎治療市場正在不斷開發針對骨關節炎預防和治療的療法，促進市場進一步成長。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章 骨關節炎治療市場變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 商業環境分析
    • 產業分析—波特五力分析
    • PESTLE分析
    • 管道分析
    • 專利到期分析
    • 定價分析

第4章 骨關節炎治療市場：依產品分類的業務分析

  • 按產品分類的市場佔有率（2024 年和 2033 年）
  • 按產品分類的市場規模、預測和趨勢分析（2021-2033 年）
  • 黏彈性補充劑
  • 富血小板血漿（PRP）療法
  • 骨移植替代物
  • 骨髓抽吸濃縮液（BMAC）療法
  • 脂肪組織療法
  • 自體軟骨細胞移植術（ACI），包括MACI
  • 幹細胞（其他）
  • 其他

第5章 骨關節炎治療市場：按應用領域分類的業務分析

  • 按應用領域分類的市場佔有率（2024 年和 2033 年）
  • 按應用領域分類的市場規模、預測和趨勢分析（2021-2033 年）
  • 膝關節骨關節炎
  • 髖關節骨關節炎
  • 肩關節骨關節炎
  • 脊椎骨關節炎
  • 踝關節和足部骨關節炎
  • 其他

第6章 骨關節炎治療市場：主要使用者業務分析

  • 主要用戶市場佔有率（2024 年和 2033 年）
  • 主要用戶市場規模、預測與趨勢分析（2021-2033）
  • 骨科醫生
  • 風濕症醫師
  • 運動醫學專家
  • 再生醫學專家
  • 其他

第7章 骨關節炎治療市場：按地區分類的估計和趨勢分析

  • 區域市場佔有率分析（2024 年和 2033 年）
  • 區域市場概覽
  • 市場規模及預測趨勢分析（2021-2033）：
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭情勢

  • 參與企業概況
  • 企業市場分析
  • 公司分類
  • 策略規劃
  • 公司簡介/列表
    • Stryker
    • Zimmer Biomet Holdings, Inc.
    • Medtronic
    • Anika Therapeutics, Inc.
    • Bioventus
    • Vericel Corporation
    • Smith &Nephew
    • Fidia Farmaceutici SpA
    • Seikagaku Corporation
    • Sanofi
Product Code: GVR-4-68040-221-7

Osteoarthritis Therapeutics Market Summary

The global osteoarthritis therapeutics market size was estimated at USD 5.02 billion in 2024 and is projected to reach USD 10.89 billion by 2033, growing at a CAGR of 9.0% from 2025 to 2033. The global osteoarthritis therapeutics market size was estimated at USD 5.02 billion in 2024 and is projected to reach USD 10.89 billion by 2033, growing at a CAGR of 9.0% from 2025 to 2033.

According to the Global Burden of Disease (GBD) Study 2020, approximately 595 million people worldwide were living with osteoarthritis, representing 7.6% of the global population. This number continues to rise, primarily due to demographic shifts and lifestyle factors such as aging and obesity. The GBD report, published in November 2024, noted a sharp increase in OA cases, with approximately 466.3 million new cases recorded in 2021 alone. The condition most commonly affects weight-bearing joints, particularly the knee, making it a growing concern for healthcare systems worldwide. The rise in OA prevalence is particularly pronounced among older populations, with data from the Centers for Disease Control and Prevention (CDC) published in February 2024 indicating that arthritis rates increase substantially with age. In adults aged 75 and older, the prevalence of arthritis is as high as 53.9%, underscoring the strong correlation between aging and OA.

The growing geriatric population is a major driver of market growth, with the World Health Organization (WHO) projecting that by 2050, 16% of the global population is expected to be aged 65 or older. As the elderly population expands, particularly in regions such as Japan and Europe where the aging demographic is more pronounced, the demand for age-specific OA treatments is rising. According to the WHO's July 2023 report, 73% of individuals living with osteoarthritis are aged 55 or older, highlighting the increasing prevalence of OA in older age groups. This demographic shift has prompted the healthcare industry to focus on therapies that address the unique needs of elderly patients, many of whom also have multiple comorbidities. As of October 2024, healthcare systems are focusing more on geriatric care, emphasizing the development of treatments that improve mobility and overall quality of life for elderly OA patients. Moreover, the growth of the elderly population is catalyzing investments in clinical research to develop innovative therapies, such as biologics and regenerative treatments, aimed at slowing disease progression and enhancing joint function.

Another significant factor driving the osteoarthritis therapeutics market is the rising incidence of sports injuries and accident-related joint damage. As participation in sports and physical activities continues to increase, so does the risk of injuries that lead to joint damage and accelerate the onset of OA. In addition to the direct impact on treatment modalities, these injuries contribute to a growing awareness of the need for joint health management. The International Labour Organization (ILO), in its 2024 report, estimated that 395 million workers worldwide sustain non-fatal work injuries annually, many of which result in long-term joint damage and subsequent OA. Furthermore, the World Health Organization (WHO) reported in 2024 that injuries account for around 4.4 million deaths annually, with a significant portion of these fatalities linked to road accidents. This growing awareness has led to increased interest in preventative measures, such as nutritional supplements, physical therapy, and the development of novel OA treatments aimed at maintaining joint health and improving recovery outcomes. As a result, the osteoarthritis therapeutics market is experiencing an uptick in the development of therapies designed to address both the prevention and treatment of OA, further contributing to market growth.

Global Osteoarthritis Therapeutics Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global osteoarthritis therapeutics market report based on product, application, primary user, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Viscosupplements
  • Platelet-Rich Plasma (PRP) Therapy
  • Bone Graft Substitutes
  • BMAC (Bone Marrow Aspirate Concentrate) Therapy
  • Adipose Tissue Therapy
  • Autologous Chondrocyte Implantation (ACI), Including MACI
  • Stem Cell (other)
  • Other (Cartilage Resurfacing Products)
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Knee Osteoarthritis
  • Hip Osteoarthritis
  • Shoulder Osteoarthritis
  • Spine Osteoarthritis
  • Ankle & Foot Osteoarthritis
  • Other
  • Primary User Outlook (Revenue, USD Million, 2021 - 2033)
  • Orthopedic Surgeons
  • Rheumatologists
  • Sports Medicine Specialists
  • Regenerative Medicine Specialists
  • Other
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. Primary User
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Osteoarthritis Therapeutics Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
    • 3.3.3. Pipeline Analysis
    • 3.3.4. Patent Expiry Analysis
    • 3.3.5. Pricing Analysis

Chapter 4. Osteoarthritis Therapeutics Market: Product Business Analysis

  • 4.1. Product Market Share, 2024 & 2033
  • 4.2. Product Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Viscosupplements
    • 4.4.1. Viscosupplements Market, 2021 - 2033 (USD Million)
  • 4.5. Platelet-Rich Plasma (PRP) Therapy
    • 4.5.1. Platelet-Rich Plasma (PRP) Therapy Market, 2021 - 2033 (USD Million)
  • 4.6. Bone Graft Substitutes
    • 4.6.1. Bone Graft Substitutes Market, 2021 - 2033 (USD Million)
  • 4.7. BMAC (Bone Marrow Aspirate Concentrate) Therapy
    • 4.7.1. BMAC (Bone Marrow Aspirate Concentrate) Therapy Market, 2021 - 2033 (USD Million)
  • 4.8. Adipose Tissue Therapy
    • 4.8.1. Adipose Tissue Therapy Market, 2021 - 2033 (USD Million)
  • 4.9. Autologous Chondrocyte Implantation (ACI), Including MACI
    • 4.9.1. Autologous Chondrocyte Implantation (ACI), Including MACI Market, 2021 - 2033 (USD Million)
  • 4.10. Stem Cell (other)
    • 4.10.1. Stem Cell (other) Market, 2021 - 2033 (USD Million)
  • 4.11. Others
    • 4.11.1. Others Market, 2021 - 2033 (USD Million)

Chapter 5. Osteoarthritis Therapeutics Market: Application Business Analysis

  • 5.1. Application Market Share, 2024 & 2033
  • 5.2. Application Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by application, 2021 to 2033 (USD Million)
  • 5.4. Knee Osteoarthritis
    • 5.4.1. Knee Osteoarthritis Market, 2021 - 2033 (USD Million)
  • 5.5. Hip Osteoarthritis
    • 5.5.1. Hip Osteoarthritis Market, 2021 - 2033 (USD Million)
  • 5.6. Shoulder Osteoarthritis
    • 5.6.1. Shoulder Osteoarthritis Market, 2021 - 2033 (USD Million)
  • 5.7. Spine Osteoarthritis
    • 5.7.1. Spine Osteoarthritis Market, 2021 - 2033 (USD Million)
  • 5.8. Ankle & Foot Osteoarthritis
    • 5.8.1. Ankle & Foot Osteoarthritis Market, 2021 - 2033 (USD Million)
  • 5.9. Others
    • 5.9.1. Others Market, 2021 - 2033 (USD Million)

Chapter 6. Osteoarthritis Therapeutics Market: Primary User Business Analysis

  • 6.1. Primary User Market Share, 2024 & 2033
  • 6.2. Primary User Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by primary user, 2021 to 2033 (USD Million)
  • 6.4. Orthopedic Surgeons
    • 6.4.1. Orthopedic Surgeons Market, 2021 - 2033 (USD Million)
  • 6.5. Rheumatologists
    • 6.5.1. Rheumatologists Market, 2021 - 2033 (USD Million)
  • 6.6. Sports Medicine Specialists
    • 6.6.1. Sports Medicine Specialists Market, 2021 - 2033 (USD Million)
  • 6.7. Regenerative Medicine Specialists
    • 6.7.1. Regenerative Medicine Specialists Market, 2021 - 2033 (USD Million)
  • 6.8. Others
    • 6.8.1. Others Market, 2021 - 2033 (USD Million)

Chapter 7. Osteoarthritis Therapeutics Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 7.4. North America
    • 7.4.1. North America Osteoarthritis Therapeutics Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Application Disease Prevalence
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Reimbursement Framework
      • 7.4.2.5. U.S. Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Application Disease Prevalence
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Reimbursement Framework
      • 7.4.3.5. U.S. Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Application Disease Prevalence
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Reimbursement Framework
      • 7.4.4.5. Mexico Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Application Disease Prevalence
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement Framework
      • 7.5.2.5. Uk Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Application Disease Prevalence
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement Framework
      • 7.5.3.5. Germany Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Application Disease Prevalence
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Reimbursement Framework
      • 7.5.4.5. France Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Application Disease Prevalence
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Reimbursement Framework
      • 7.5.5.5. Italy Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Application Disease Prevalence
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Reimbursement Framework
      • 7.5.6.5. Spain Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Application Disease Prevalence
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Reimbursement Framework
      • 7.5.7.5. Denmark Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Application Disease Prevalence
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Reimbursement Framework
      • 7.5.8.5. Sweden Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Application Disease Prevalence
      • 7.5.9.3. Regulatory Framework
      • 7.5.9.4. Reimbursement Framework
      • 7.5.9.5. Norway Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Application Disease Prevalence
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement Framework
      • 7.6.2.5. Japan Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Application Disease Prevalence
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement Framework
      • 7.6.3.5. China Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Application Disease Prevalence
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement Framework
      • 7.6.4.5. India Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Application Disease Prevalence
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement Framework
      • 7.6.5.5. Australia Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Application Disease Prevalence
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Reimbursement Framework
      • 7.6.6.5. South Korea Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Application Disease Prevalence
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Reimbursement Framework
      • 7.6.7.5. Thailand Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Application Disease Prevalence
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Reimbursement Framework
      • 7.7.2.5. Japan Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Application Disease Prevalence
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Reimbursement Framework
      • 7.7.3.5. China Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8. Middle East and Africa
    • 7.8.1. Middle East and Africa Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Application Disease Prevalence
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Reimbursement Framework
      • 7.8.2.5. South Africa Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Application Disease Prevalence
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Reimbursement Framework
      • 7.8.3.5. Saudi Arabia Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Application Disease Prevalence
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. Reimbursement Framework
      • 7.8.4.5. UAE Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Application Disease Prevalence
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Reimbursement Framework
      • 7.8.5.5. Kuwait Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Stryker
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Zimmer Biomet Holdings, Inc.
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Medtronic
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Anika Therapeutics, Inc.
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Bioventus
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Vericel Corporation
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Smith & Nephew
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. Fidia Farmaceutici S.p.A.
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. Seikagaku Corporation
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Sanofi
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global osteoarthritis therapeutics market, by region, 2021 - 2033 (USD Million)
  • Table 4 Global osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 5 Global osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 6 Global osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 7 North America osteoarthritis therapeutics market, by country, 2021 - 2033 (USD Million)
  • Table 8 North America osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 9 North America osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 10 North America osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 11 U.S. osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 12 U.S. osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 13 U.S. osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 14 Canada osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 15 Canada osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 16 Canada osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 17 Mexico osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 18 Mexico osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 19 Mexico osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 20 Europe osteoarthritis therapeutics market, by country, 2021 - 2033 (USD Million)
  • Table 21 Europe osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 22 Europe osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 23 Europe osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 24 UK osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 25 UK osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 26 UK osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 27 Germany osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 28 Germany osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 29 Germany osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 30 France osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 31 France osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 32 France osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 33 Italy osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 34 Italy osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 35 Italy osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 36 Spain osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 37 Spain osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 38 Spain osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 39 Norway osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 40 Norway osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 41 Norway osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 42 Denmark osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 43 Denmark osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 44 Denmark osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 45 Sweden osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 46 Sweden osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 47 Sweden osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific osteoarthritis therapeutics market, by country, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 51 Asia Pacific osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 52 Japan osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 53 Japan osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 54 Japan osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 55 China osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 56 China osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 57 China osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 58 India osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 59 India osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 60 India osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 61 Australia osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 62 Australia osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 63 Australia osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 64 South Korea osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 65 South Korea osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 66 South Korea osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 67 Thailand osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 68 Thailand osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 69 Thailand osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 70 Latin America osteoarthritis therapeutics market, by country, 2021 - 2033 (USD Million)
  • Table 71 Latin America osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 72 Latin America osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 73 Latin America osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 74 Brazil osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 75 Brazil osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 76 Brazil osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 77 Argentina osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 78 Argentina osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 79 Argentina osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 80 Middle East & Africa Osteoarthritis therapeutics market, by country, 2021 - 2033 (USD Million)
  • Table 81 Middle East & Africa osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 82 Middle East & Africa osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 83 Middle East & Africa osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 84 South Africa osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 85 South Africa osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 86 South Africa osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 89 Saudi Arabia osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 90 UAE osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 91 UAE osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 92 UAE osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)
  • Table 93 Kuwait osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
  • Table 94 Kuwait osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
  • Table 95 Kuwait osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Osteoarthritis therapeutics market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Therapeutic approach outlook (USD Million)
  • Fig. 10 Competitive landscape
  • Fig. 11 Osteoarthritis therapeutics market dynamics
  • Fig. 12 Osteoarthritis therapeutics market: Porter's five forces analysis
  • Fig. 13 Osteoarthritis therapeutics market: PESTLE analysis
  • Fig. 14 Product market, 2021 - 2033 (USD Million)
  • Fig. 15 Viscosupplements market, 2021 - 2033 (USD Million)
  • Fig. 16 Platelet-Rich Plasma (PRP) Therapy market, 2021 - 2033 (USD Million)
  • Fig. 17 Bone Graft Substitutes market, 2021 - 2033 (USD Million)
  • Fig. 18 BMAC (Bone Marrow Aspirate Concentrate) Therapy market, 2021 - 2033 (USD Million)
  • Fig. 19 Adipose Tissue Therapy market, 2021 - 2033 (USD Million)
  • Fig. 20 Autologous Chondrocyte Implantation (ACI), Including MACI market, 2021 - 2033 (USD Million)
  • Fig. 21 Stem Cell (other) Substitutes market, 2021 - 2033 (USD Million)
  • Fig. 22 Others market, 2021 - 2033 (USD Million)
  • Fig. 23 Application market, 2021 - 2033 (USD Million)
  • Fig. 24 Knee Osteoarthritis market, 2021 - 2033 (USD Million)
  • Fig. 25 Hip Osteoarthritis market, 2021 - 2033 (USD Million)
  • Fig. 26 Shoulder Osteoarthritis market, 2021 - 2033 (USD Million)
  • Fig. 27 Spine Osteoarthritis market, 2021 - 2033 (USD Million)
  • Fig. 28 Ankle & Foot Osteoarthritis market, 2021 - 2033 (USD Million)
  • Fig. 29 Others market, 2021 - 2033 (USD Million)
  • Fig. 30 Primary User market, 2021 - 2033 (USD Million)
  • Fig. 31 Orthopedic Surgeons market, 2021 - 2033 (USD Million)
  • Fig. 32 Rheumatologists market, 2021 - 2033 (USD Million)
  • Fig. 33 Sports Medicine Specialists market, 2021 - 2033 (USD Million)
  • Fig. 34 Regenerative Medicine Specialists market, 2021 - 2033 (USD Million)
  • Fig. 35 Others market, 2021 - 2033 (USD Million)
  • Fig. 36 Osteoarthritis therapeutics market revenue, by region
  • Fig. 37 Regional marketplace: Key takeaways
  • Fig. 38 North America osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 39 U.S. country dynamics
  • Fig. 40 U.S. osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 41 Canada country dynamics
  • Fig. 42 Canada osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 43 Mexico country dynamics
  • Fig. 44 Mexico osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 45 Europe osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 46 UK country dynamics
  • Fig. 47 UK osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 48 Germany country dynamics
  • Fig. 49 Germany osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 50 France country dynamics
  • Fig. 51 France osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 52 Italy country dynamics
  • Fig. 53 Italy osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 54 Spain country dynamics
  • Fig. 55 Spain osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 56 Norway country dynamics
  • Fig. 57 Norway osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 58 Sweden country dynamics
  • Fig. 59 Sweden osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 60 Denmark country dynamics
  • Fig. 61 Denmark osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 62 Asia Pacific osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 63 Japan country dynamics
  • Fig. 64 Japan osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 65 China country dynamics
  • Fig. 66 China osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 67 India country dynamics
  • Fig. 68 India osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 69 Australia country dynamics
  • Fig. 70 Australia osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 71 South Korea country dynamics
  • Fig. 72 South Korea osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 73 Thailand country dynamics
  • Fig. 74 Thailand osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 75 Latin America osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 76 Brazil country dynamics
  • Fig. 77 Brazil osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 78 Argentina country dynamics
  • Fig. 79 Argentina osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 80 MEA osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 81 South Africa country dynamics
  • Fig. 82 South Africa osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 83 Saudi Arabia country dynamics
  • Fig. 84 Saudi Arabia osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 85 UAE country dynamics
  • Fig. 86 UAE osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 87 Kuwait country dynamics
  • Fig. 88 Kuwait osteoarthritis therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 89 Company categorization
  • Fig. 90 Company market position analysis
  • Fig. 91 Strategic framework